A case of HER2-positive stage IV advanced gastric cancer treated with chemotherapy combined with trastuzumab

Kai Takaya, Ryosuke Takahashi, Satoru Honma, Shinichiro Horii, Hirokazu Takahashi, Motohisa Hagiwara, Masahiro Chin, Eiji Hashizume

研究成果: Article査読

1 被引用数 (Scopus)

抄録

We report a case of human epidermal growth factor receptor (HER) 2 positive stage IV advanced gastric cancer successfully treated with chemotherapy combined with trastuzumab. A 50-year-old man was diagnosed with type 3 gastric cancer complicated by liver and lymph node metastases. Owing to a HER2 immunohistochemistry tumor score of 3+, we initiated capecitabine plus CDDP plus trastuzumab chemotherapy. After 6 chemotherapy courses, computed tomography showed the liver metastasis had disappeared and the paraaortic lymph nodes had shrunk. We continued the capecitabine plus trastuzumab chemotherapy, which resulted in a progression free survival of 31 months. After 38 chemotherapy courses, the primary tumor progressed; therefore, the patient underwent surgery. Chemotherapy combined with trastuzumab can allow for resection of the primary tumor.

本文言語English
ページ(範囲)1113-1116
ページ数4
ジャーナルJapanese Journal of Cancer and Chemotherapy
43
9
出版ステータスPublished - 2016 9月
外部発表はい

ASJC Scopus subject areas

  • 腫瘍学
  • 癌研究

フィンガープリント

「A case of HER2-positive stage IV advanced gastric cancer treated with chemotherapy combined with trastuzumab」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル